Capricor Therapeutics Inc (CAPR) — Capital Reinvestment Ratio
Capricor Therapeutics Inc (CAPR) has a Capital Reinvestment Ratio of 0.11x as of March 2023, meaning it reinvests 0% of its operating cash flow ($4.21 Million) in capital expenditures ($453.12K). See Capricor Therapeutics Inc balance sheet independence to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capricor Therapeutics Inc Capital Reinvestment Ratio (2014–2022)
This chart tracks Capricor Therapeutics Inc's Capital Reinvestment Ratio across 2 annual periods. Check Capricor Therapeutics Inc (CAPR) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Capricor Therapeutics Inc (2014–2022)
Year-by-year Capital Reinvestment Ratio for Capricor Therapeutics Inc from 2014 to 2022. For live market cap and broader valuation context, see Capricor Therapeutics Inc market cap and net worth.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 0.68x | $4.92 Million | $3.36 Million | ▲ +251.3% |
| 2014 | 0.19x | $958.56K | $186.43K | — |